Cicchetti, Americo
 Distribuzione geografica
Continente #
EU - Europa 7.484
NA - Nord America 5.568
AS - Asia 1.064
AF - Africa 87
SA - Sud America 81
OC - Oceania 60
Continente sconosciuto - Info sul continente non disponibili 16
Totale 14.360
Nazione #
US - Stati Uniti d'America 5.443
IT - Italia 3.451
DE - Germania 1.277
SE - Svezia 900
CN - Cina 572
UA - Ucraina 440
FR - Francia 386
IE - Irlanda 272
GB - Regno Unito 220
FI - Finlandia 132
IN - India 114
TR - Turchia 100
CA - Canada 91
BE - Belgio 69
PL - Polonia 49
NL - Olanda 48
AU - Australia 46
IR - Iran 46
BR - Brasile 43
ES - Italia 42
CH - Svizzera 40
HK - Hong Kong 31
RU - Federazione Russa 30
MY - Malesia 29
SG - Singapore 29
ID - Indonesia 25
NO - Norvegia 19
AT - Austria 18
CZ - Repubblica Ceca 18
JP - Giappone 18
KE - Kenya 17
PT - Portogallo 17
EG - Egitto 16
MX - Messico 16
EU - Europa 15
VN - Vietnam 15
CO - Colombia 14
NZ - Nuova Zelanda 14
AR - Argentina 11
KR - Corea 10
PK - Pakistan 10
HN - Honduras 9
PH - Filippine 9
RO - Romania 9
ZA - Sudafrica 9
TW - Taiwan 8
BD - Bangladesh 7
ET - Etiopia 7
GR - Grecia 7
CI - Costa d'Avorio 6
DZ - Algeria 6
MA - Marocco 6
MD - Moldavia 6
PE - Perù 6
SI - Slovenia 6
DK - Danimarca 5
HR - Croazia 5
IQ - Iraq 5
BG - Bulgaria 4
LB - Libano 4
MZ - Mozambico 4
TH - Thailandia 4
BN - Brunei Darussalam 3
CY - Cipro 3
GH - Ghana 3
IL - Israele 3
NA - Namibia 3
NP - Nepal 3
RS - Serbia 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
CM - Camerun 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EC - Ecuador 2
GE - Georgia 2
JM - Giamaica 2
KW - Kuwait 2
LK - Sri Lanka 2
LT - Lituania 2
MV - Maldive 2
SK - Slovacchia (Repubblica Slovacca) 2
TZ - Tanzania 2
UY - Uruguay 2
VG - Isole Vergini Britanniche 2
AL - Albania 1
AP - ???statistics.table.value.countryCode.AP??? 1
BZ - Belize 1
EE - Estonia 1
HU - Ungheria 1
JO - Giordania 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MC - Monaco 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
MW - Malawi 1
NG - Nigeria 1
QA - Qatar 1
Totale 14.353
Città #
Chandler 1.039
Ashburn 380
Rome 380
Milan 347
Ann Arbor 333
Jacksonville 320
Dublin 272
San Mateo 213
Cattolica 161
Nanjing 139
Wilmington 138
Woodbridge 118
Plan 117
Marseille 114
Redwood City 109
New York 107
Dearborn 98
Boston 87
Houston 87
Fairfield 76
Beijing 74
Lawrence 71
Bremen 70
Mountain View 70
Princeton 68
Seattle 68
Boardman 61
Nanchang 61
Brussels 58
Munich 56
Bologna 51
Nürnberg 51
Turin 45
Izmir 43
Lancaster 43
Bari 38
Torino 37
Helsinki 36
Shanghai 35
Paris 34
Florence 33
Redmond 32
Frattamaggiore 30
Hangzhou 30
Augusta 29
Shenyang 28
Kuala Lumpur 27
Cambridge 26
Chicago 26
Falls Church 26
Naples 26
Pune 26
Modena 25
Ottawa 25
Tianjin 25
Trieste 25
Andover 24
Changsha 24
Norwalk 24
Leawood 23
Palermo 22
Kunming 21
Moncalieri 20
Trento 20
Verona 20
Nutley 19
Padova 19
Fremont 18
Jiaxing 17
Pisa 17
Enterprise 16
Hebei 16
London 16
Pescara 16
Busto Arsizio 15
Guangzhou 15
Radal 15
Segrate 15
Amsterdam 14
Duncan 14
Los Angeles 14
Nairobi 14
San Diego 14
Warsaw 14
Botucatu 13
Saint Petersburg 13
Brescia 12
Perugia 12
Vienna 12
Ankara 11
Auckland 11
Napoli 11
Piano Di Sorrento 11
Piombino 11
Porto San Giorgio 11
Simi Valley 11
Taranto 11
Zhengzhou 11
Campobasso 10
Edinburgh 10
Totale 6.821
Nome #
The AdHopHTA handbook: a handbook of hospital-based Health Technology Assessment (HB-HTA) 551
I costi socio-sanitari dell’insufficienza renale cronica 549
Igiene, Medicina Preventiva, Sanità Pubblica. Seconda Edizione 477
Return-on-Investment of Workplace Health Promotion programs: New Total Worker Health® strategies in the framework of the “One Health” approach 396
Innovazione organizzativa e ruoli emergenti in sanità 393
L'analisi dei network organizzativinei sistemi sanitari: il caso della rete di emergenza della Regione Lazio 338
Innovazione organizzativa e ruoli emergenti in sanità 260
Measuring organizational performance. A review of the dimensions of hospital performance indicators [Pitch presentation] 222
HTA of alternative methods of pathogen inactivation of fresh frozen plasma 221
Misurare le prestazioni organizzative. Revisione delle dimensioni degli indicatori di performance ospedaliera [Poster] 204
NutriCatt protocol in the enhanced recovery after surgery (ERAS) program for colorectal surgery: the nutritional support improves clinical and cost-effectiveness outcomes. 200
Un innovativo incentivo per aumentare l’aderenza alla vaccinazione antinfluenzale tra gli operatori sanitari: analisi cost-consequence e valutazione di sostenibilità. 181
The ethical assessment in HTA reports: the development and the evolution of the ethics consultation by Institute of Bioethics of the Università Cattolica del Sacro Cuore, Rome (Italy) 167
Economia sanitaria 167
Full HTA di Emicizumab 157
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 153
IL RUOLO DELL’HEALTH TECHNOLOGY ASSESSMENT NELLA DEFINIZIONE DEI LIVELLI ESSENZIALI DI ASSISTENZA 149
How could Ethical, Legal, Social & Organizational issues be further integrated in HTA processes? A proposal of “extended” ELSI logics: justifications and considerations moving from the debate and the experience. 143
Economia sanitaria 141
Copertura vaccinale antinfluenzale e assenteismo per malattia negli Operatori Sanitari di un Policlinico Universitario Italiano 140
Factors associated with health-related quality of life: the role of social relationships among the elderly in an Italian region 134
La definizione delle priorità nel processo di HTA. Tra esigenze centrali e regionali 134
Il caso del Policlinico A. Gemelli 134
The “triangular model” applied to drug eluting stents (DES) 128
Health Technology Assessment di ausili assorbenti per l’incontinenza urinaria 128
Lo sviluppo della consulenza etica nei processi di HTA: i dati preliminari dell'esperienza dell'Istituto di Bioetica dell'Università Cattolica del Sacro Cuore (Roma) 127
Flu vaccination and value-based health care: operational solutions to safeguard public health 125
L'HB-HTA: esperienze, buone pratiche e strumenti del progetto europeo AdHopHTA 123
Hospital contextual factors affecting the use of health technologies: a systematic review [Poster display] 122
Valutazione costo-efficacia del percorso dei pazienti a rischio di epatite B sottoposti a test anti-HBV 119
Return on investment (ROI) and development of a workplace disability management program in a hospital—a pilot evaluation study 117
Health Technology Assessment and vaccine: new needs and opportunities? 116
Il modello WEF per la valutazione economica delle innovazioni terapeutiche in epatologia. 116
EXPLORING THE ROLE OF PROFESSIONAL NETWORKS ON THE DIFFUSION OF MEDICAL TECHNOLOGIES: AN EMPIRICAL STUDY ON ROBOTIC SURGERY 111
Organizational Models of Hospital Based HTA: Empirical Evidence from Adhophta European Project 111
Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use 110
Prioritization of high-cost new drugs for HCV: making sustainability ethical 109
Cost Effectiveness Analysis of Instanyl for the Treatment of Breakthrough Cancer Pain (BtcP) 109
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 107
Balanced Scorecard for performance assessment in healthcare settings: a review of literature 106
The harmonic study: cost-effectiveness evaluation of the use of the ultrasonic scalpel in total thyroidectomy 104
Diffusione dei modelli dipartimentali nelle aziende sanitarie italiane 102
Ethical assessment of hepatitis C virus treatment: The lesson from first generation protease inhibitors 102
La diffusione del modello dipartimentale nel SSN: un fatto solo formale? 99
Health Technology Assessment of the anti HCV strategies in Italy: evidences from the WEF Project 98
The diffusion and impact of the divisional model in Italian National Health service Hospitals 94
Healthcare expenditure on prevention in the spending review era 94
Descrizione degli Indicatori e Fonti dei dati 93
Hta e decision making: proposte e risultati dell’Health policy forum 92
Il ruolo degli stakeholder nel processo di Health Technology Assessment 92
Use of robot-specific resources and operating room times: the case of Telelap Alf-X robotic hysterectomy 90
Money back guarantee? A cost–benefit framework of performance-based agreements (PBAs) for the reimbursement of pharmaceuticals 90
INDIVIDUARE, FINANZIARE E COMUNICARE L’INNOVAZIONE IN SANITÀ: IL RUOLO DELL’HEALTH TECHNOLOGY ASSESSMENT 90
MONITORING REGISTRIES AT ITALIAN MEDICINES AGENCY: FOSTERING ACCESS, GUARANTEEING SUSTAINABILITY. 89
Il dipartimento non è di carta 88
Descrizione degli Indicatori e Fonti dei dati 88
Healthcare Reform, Quality and Safety. Perspectives, Participants and Prospects in 30 countries 88
L'approccio metodologico 88
Extending influenza vaccination to individuals aged 50–64: A budget impact analysis 86
Il punto di vista delle aziende 84
Looking good or doing better? Patterns of decoupling in the implementation of Clinical Directorates 84
Investigating the generalizability of Economic Evaluations conducted in Italy: a critical review 84
Linking the Price of Cancer Drug Treatments to Their Clinical Value 84
Assessing social and Economic Impact of Subcutaneous Mabs in Oncology 84
Harmonic study: A cost-effectiveness evaluation of ultrasonically activated shears for total thyroidectomy [Lo studio HARMONIC: Valutazione costo-efficacia dell'uso del bisturi a ultrasuoni negli interventi di tiroidectomia totale] 83
Health technology assessment in Italy 82
The use of harmonic scalpel versus knot tying for conventional open thyroidectomy: results of a prospective randomized study 81
Hospital restructuring and physician job satisfaction: An empirical study 80
Valutazione economica dei programmi di screening contro il cancro del colon retto: evidenze indirette di lungo periodo e sostenibilita` finanziaria in un’ottica di programmazione regionale 80
Descrizione degli Indicatori e Fonti dei dati 79
Unfolding similarity in interphysician networks: the impact of institutional and professional homophily 79
Unfolding similarity in interphysician networks: the Impact of Institutional and Professional Homophily 79
The cost-effectiveness of alternative strategies against HBV in Italy 78
L’utilizzo di modelli decisionali per le valutazioni economiche dei farmaci in Italia: stato dell’arte e prospettive future 78
Assessing social and economic impact of subcutaneous mAbs in oncology 76
Ethical assessment of hepatitis C virus treatment: The lesson from first generation protease inhibitors 76
Il ruolo delle competenze dei rappresentanti dei cittadini: evidenze dalle associazioni italiane dedite all'advocacy 75
Activity-based costing analysis of the analgesic treatments used in postoperative pain management in Italy. 74
Economic assessment of an anti-HCV screening program in Italy 73
A new decision model for economic evaluation of novel therapies for HCV 73
Valutazione multidimensionale e multidisciplinare del servizio di consegna domiciliare dei presidi medici per stomia e incontinenza 73
Ruolo e Regole degli stakeholder nel processo di HTA. Le Evidenze emerse dall’Health Policy Forum della SIHTA 72
Sustainability of a public system for plasma collection, contract fractionation and plasma-derived medicinal product manufacturing 71
GUIDING PRINCIPLES FOR GOOD PRACTICES IN HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT UNITS. 71
Economic assessment of Zostavax vaccine for the prevention of Herpes Zoster 71
Risk factors for mortality and cost implications of complicated intra-abdominal infections in critically ill patients 71
Looking good or doing better? Patterns of decoupling in the implementation of clinical directorates. 70
Dealing with COVID-19 epidemic in Italy: Responses from regional organizational models during the first phase of the epidemic 70
THE HARMONIC STUDY: COST-EFFECTIVENESS EVALUATION OF THE USE OF THE ULTRASONIC SCALPEL IN TOTAL THYROIDECTOMY. 69
Come comunicare e trasferire i risultati delle valutazioni di HTA applicata alle vaccinazioni ai decision makers e agli stakeholders? il progetto dell’ISPOR Rome chapter 69
Cost-consequence analysis of influenza vaccination among the staff of a large teaching hospital in Rome, Italy: A pilot study 68
Lo studio HARMONIC: valutazione costo-efficacia dell’uso del bisturi a ultrasuoni negli interventi di tiroidectomia totale 67
Budget impact of implementing platelet pathogen reduction into the Italian blood transfusion system 66
“Farmaci insostenibili” e giustizia intergenerazionale in Sanità 65
Dynamic analysis of interhospital collaboration and competition: Empirical evidence from an Italian regional health system 64
"Us and Them": a social network analysis of physicians' professional networks and their attitudes towards EBM 64
Economic Assessment of an Anti-HCV Screening Program in Italy 63
Artificial neural networks and their potentialities in analyzing budget health data: an application for Italy of what-if theory. 63
Il position paper OSSFOR. HTA dei piccoli numeri 63
Physicians' propensity to collaborate and their attitude towards EBM: A cross-sectional study 62
Totale 12.380
Categoria #
all - tutte 42.381
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.381


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019223 0 0 0 0 0 0 0 0 0 51 100 72
2019/20201.618 312 75 97 51 122 125 191 54 178 107 161 145
2020/20211.688 133 221 59 150 184 110 134 81 211 94 227 84
2021/20221.993 145 130 56 105 174 79 132 250 113 166 322 321
2022/20233.728 429 431 285 523 248 391 223 332 402 140 221 103
2023/20242.249 145 514 116 238 175 305 205 239 143 169 0 0
Totale 14.616